Lam Research Investing Cash Flow decreased by 43.9% to -$186.05M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 68.3%, from -$110.55M to -$186.05M. Over 3 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 113.0% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $689.06M | $596.69M | -$991.74M | $1.08B | -$127.80M | -$48.84M | -$302.74M | -$55.18M | -$74.68M | -$211.24M | $0.00 | -$101.61M | -$110.55M | -$333.28M | -$135.01M | -$129.25M | -$186.05M |
| QoQ Change | — | -13.4% | -266.2% | +209.2% | -111.8% | +61.8% | -519.9% | +81.8% | -35.3% | -182.9% | +100.0% | — | -8.8% | -201.5% | +59.5% | +4.3% | -43.9% |
| YoY Change | — | — | — | — | -121.4% | +95.1% | -127.9% | — | +41.6% | -332.5% | +100.0% | -84.1% | -48.0% | -57.8% | — | -27.2% | -68.3% |